Sign in
Active, not recruitingNo phase

EVEREST-HN-3: Linkage of National Data Sets for Suspected Head-and-neck Cancer Referrals

Key facts

Who runs it
Royal Marsden NHS Foundation Trust
Where
United Kingdom2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
125,000 people, planned
Started
1 Sept 2026
Expected to end
31 Aug 2028
Type of study
Observational, 2 groups
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Referred for suspected head-and-neck cancer (according to Cancer Waiting Times data)
  • Diagnosed with head-and-neck cancer (according to National Cancer Registration data) based on International Classification of Diseases 10th Edition (ICD10) codes: oral cavity (C00, C03-C06), tongue (C01-C02), pharynx (C09-C10, C12-C14), nose (C30-C31), larynx (C32), skin (C43 - C44), and thyroid (C73)

Who cannot take part

  • None

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to get a better understanding which patient characteristics, available in routinely collected data, are associated with the probability that patients referred because of suspected head-and-neck cancer will receive a head-and-neck cancer diagnosis.

Read full original descriptionShow less

Participants will not be recruited specifically for this study. Instead, we will be using routinely-collected national electronic health records linked at patient level, including the National Cancer Waiting Times Monitoring Data (CWT), the National Cancer Registration Data set (NCRD), the Radiotherapy Data set (RTDS), the Systemic Anti-Cancer Therapy Data set (SACT) and the Hospital Episode Statistics.

The main questions it aims to answer are:

1. To describe the patients who are referred with a suspected head-and-neck cancer diagnosis and those who have a confirmed diagnosis. 2. To create a typology of the diagnostic pathway across the country (e.g., comparing 21 regions reflecting the Cancer Alliances). 3. To explore differences among the 21 National Health Service Cancer Alliances in the referral rates of patients with suspected head-and-neck cancer and the number of referred patients in whom a cancer can be diagnosed. 4. To develop a prognostic model that can predict the probability that referred patients will receive a head-and-neck cancer diagnosis. 5. To evaluate the value of Hospital Episode Statistics (HES), National Cancer Registration Data (NCRD), Radiotherapy Data Set (RTDS) and Systemic Anti-Cancer Therapy (SACT) data to monitor referral pathways for patients with suspected head-and-neck cancer. 6. To develop a health economic model of the diagnostic and treatment pathways of referrals for suspected head-and-neck cancer. 7. To assess hospital care costs across the diagnostic and treatment pathways for head and neck cancer.

The 2 groups in the trial

  • Patients referred for suspected head and neck cancer in Cancer Waiting Times

    All patients referred for suspected head-and-neck cancer according to the Cancer Waiting Times dataset (01 April 2018 to most recent available) will be included. The cohort definition is based on International Classification of Diseases 10th Edition (ICD-10) codes, defining site-specific cancers in oral cavity, tongue, pharynx, and larynx (C00-C14; C30-C32; C43.0 - C43.4; C44.3; C44.4; C73.0; C76.0; C77.0).

  • Pateints with recorded head and neck cancer diagnosis in National Cancer Registrations Data

    All patients with a confirmed head-and-neck cancer diagnosis between 1 January 2018 and 31 December 2024 according to the National Cancer Registry will be included. The cohort definition is based on International Classification of Diseases 10th Edition (ICD-10) codes, defining site-specific cancers in oral cavity, tongue, pharynx, and larynx (C00-C14; C30-C32; C43.0 - C43.4; C44.3; C44.4; C73.0; C76.0; C77.0).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem to Redesign the Suspected Head-and-neck Cancer Referral Pathway: Informatics Linkage of National Data Sets for Suspected Head-and-neck Cancer Referrals
Record updated
12 November 2026